505 research outputs found
A Nonsmooth Maximum Principle for Optimal Control Problems with State and Mixed Constraints-Convex Case
Here we derive a nonsmooth maximum principle for optimal control problems
with both state and mixed constraints. Crucial to our development is a
convexity assumption on the "velocity set". The approach consists of applying
known penalization techniques for state constraints together with recent
results for mixed constrained problems.Comment: Published in 'Discrete and Continuous Dynamical Systems, Vol. 2011,
pp. 174-18
A variant of nonsmooth maximum principle for state constrained problems
We derive a variant of the nonsmooth maximum principle for problems with pure
state constraints. The interest of our result resides on the nonsmoothness
itself since, when applied to smooth problems, it coincides with known results.
Remarkably, in the normal form, our result has the special feature of being a
sufficient optimality condition for linearconvex problems, a feature that the
classical Pontryagin maximum principle had whereas the nonsmooth version had
not. This work is distinct to previous work in the literature since, for state
constrained problems, we add the Weierstrass conditions to adjoint inclusions
using the joint subdifferentials with respect to the state and the control. Our
proofs use old techniques developed in [16], while appealing to new results in
[7].Comment: 6 pages, No figures, Conference Proceeding
Mathematical Model Applied to Green Building Concept for Sustainable Cities Under Climate Change
Recently the effect of greenhouse gases (GHGs) is worldwide terrified anxiety to the public and scholars. Even this global problem is one of the great issues that continuously makes worrying the governments and environmentalists, but its solution findings are not out of the image at all. In this study, we have proposed and analysed a mathematical model for the solvable management of GHGs by sowing the seeds of green building dynamic systems. Moreover, in the model, the human community is used to enhance the production power of individuals of green buildings by absorbing the GHGs. The model is analysed by stability analysis at the equilibrium points: trivial and global equilibrium, and also by convincing the stability and instability of the system of equations. The behaviour of the propound model has been developed by numerical simulations which shows the rate of the fruitfulness of GHG components
Modeling and numerical analysis for mechanical characterization of soft tissue mechanism applying inverse finite element technique
Tissue-mimicking materials [e.g., polyvinyl alcohol cryogel (PVA-C)] are extensively used in clinical applications such as tissue repair and tissue engineering. Various mechanical testing techniques have been used to assess the biomechanical compatibility of tissue-mimicking materials. This article presents the development of inverse finite element (FE) techniques that are solved using numerical optimization to characterize the mechanical properties of PVA-C specimens. In this study, a numerical analysis where the displacement influence factor was employed in conjunction with a linear elastic model of finite thickness was performed. In the analysis, the effects of Poisson's ratio, specimen aspect ratio, and relative indentation depth were investigated, and a novel mathematical term was introduced to Sneddon's equation. In addition, a robust optimization algorithm was developed in MATLAB that utilized FE modeling for parameter estimation before it was rigorously validated
Recommended from our members
Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
BACKGROUND Regular, detailed reporting on population health by underlying cause of death is fundamental for public health decision making. Cause-specific estimates of mortality and the subsequent effects on life expectancy worldwide are valuable metrics to gauge progress in reducing mortality rates. These estimates are particularly important following large-scale mortality spikes, such as the COVID-19 pandemic. When systematically analysed, mortality rates and life expectancy allow comparisons of the consequences of causes of death globally and over time, providing a nuanced understanding of the effect of these causes on global populations. METHODS The Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2021 cause-of-death analysis estimated mortality and years of life lost (YLLs) from 288 causes of death by age-sex-location-year in 204 countries and territories and 811 subnational locations for each year from 1990 until 2021. The analysis used 56 604 data sources, including data from vital registration and verbal autopsy as well as surveys, censuses, surveillance systems, and cancer registries, among others. As with previous GBD rounds, cause-specific death rates for most causes were estimated using the Cause of Death Ensemble model-a modelling tool developed for GBD to assess the out-of-sample predictive validity of different statistical models and covariate permutations and combine those results to produce cause-specific mortality estimates-with alternative strategies adapted to model causes with insufficient data, substantial changes in reporting over the study period, or unusual epidemiology. YLLs were computed as the product of the number of deaths for each cause-age-sex-location-year and the standard life expectancy at each age. As part of the modelling process, uncertainty intervals (UIs) were generated using the 2·5th and 97·5th percentiles from a 1000-draw distribution for each metric. We decomposed life expectancy by cause of death, location, and year to show cause-specific effects on life expectancy from 1990 to 2021. We also used the coefficient of variation and the fraction of population affected by 90% of deaths to highlight concentrations of mortality. Findings are reported in counts and age-standardised rates. Methodological improvements for cause-of-death estimates in GBD 2021 include the expansion of under-5-years age group to include four new age groups, enhanced methods to account for stochastic variation of sparse data, and the inclusion of COVID-19 and other pandemic-related mortality-which includes excess mortality associated with the pandemic, excluding COVID-19, lower respiratory infections, measles, malaria, and pertussis. For this analysis, 199 new country-years of vital registration cause-of-death data, 5 country-years of surveillance data, 21 country-years of verbal autopsy data, and 94 country-years of other data types were added to those used in previous GBD rounds. FINDINGS The leading causes of age-standardised deaths globally were the same in 2019 as they were in 1990; in descending order, these were, ischaemic heart disease, stroke, chronic obstructive pulmonary disease, and lower respiratory infections. In 2021, however, COVID-19 replaced stroke as the second-leading age-standardised cause of death, with 94·0 deaths (95% UI 89·2-100·0) per 100 000 population. The COVID-19 pandemic shifted the rankings of the leading five causes, lowering stroke to the third-leading and chronic obstructive pulmonary disease to the fourth-leading position. In 2021, the highest age-standardised death rates from COVID-19 occurred in sub-Saharan Africa (271·0 deaths [250·1-290·7] per 100 000 population) and Latin America and the Caribbean (195·4 deaths [182·1-211·4] per 100 000 population). The lowest age-standardised death rates from COVID-19 were in the high-income super-region (48·1 deaths [47·4-48·8] per 100 000 population) and southeast Asia, east Asia, and Oceania (23·2 deaths [16·3-37·2] per 100 000 population). Globally, life expectancy steadily improved between 1990 and 2019 for 18 of the 22 investigated causes. Decomposition of global and regional life expectancy showed the positive effect that reductions in deaths from enteric infections, lower respiratory infections, stroke, and neonatal deaths, among others have contributed to improved survival over the study period. However, a net reduction of 1·6 years occurred in global life expectancy between 2019 and 2021, primarily due to increased death rates from COVID-19 and other pandemic-related mortality. Life expectancy was highly variable between super-regions over the study period, with southeast Asia, east Asia, and Oceania gaining 8·3 years (6·7-9·9) overall, while having the smallest reduction in life expectancy due to COVID-19 (0·4 years). The largest reduction in life expectancy due to COVID-19 occurred in Latin America and the Caribbean (3·6 years). Additionally, 53 of the 288 causes of death were highly concentrated in locations with less than 50% of the global population as of 2021, and these causes of death became progressively more concentrated since 1990, when only 44 causes showed this pattern. The concentration phenomenon is discussed heuristically with respect to enteric and lower respiratory infections, malaria, HIV/AIDS, neonatal disorders, tuberculosis, and measles. INTERPRETATION Long-standing gains in life expectancy and reductions in many of the leading causes of death have been disrupted by the COVID-19 pandemic, the adverse effects of which were spread unevenly among populations. Despite the pandemic, there has been continued progress in combatting several notable causes of death, leading to improved global life expectancy over the study period. Each of the seven GBD super-regions showed an overall improvement from 1990 and 2021, obscuring the negative effect in the years of the pandemic. Additionally, our findings regarding regional variation in causes of death driving increases in life expectancy hold clear policy utility. Analyses of shifting mortality trends reveal that several causes, once widespread globally, are now increasingly concentrated geographically. These changes in mortality concentration, alongside further investigation of changing risks, interventions, and relevant policy, present an important opportunity to deepen our understanding of mortality-reduction strategies. Examining patterns in mortality concentration might reveal areas where successful public health interventions have been implemented. Translating these successes to locations where certain causes of death remain entrenched can inform policies that work to improve life expectancy for people everywhere. FUNDING Bill & Melinda Gates Foundation
Global, regional, and national progress towards Sustainable Development Goal 3.2 for neonatal and child health: all-cause and cause-specific mortality findings from the Global Burden of Disease Study 2019
Background Sustainable Development Goal 3.2 has targeted elimination of preventable child mortality, reduction of neonatal death to less than 12 per 1000 livebirths, and reduction of death of children younger than 5 years to less than 25 per 1000 livebirths, for each country by 2030. To understand current rates, recent trends, and potential trajectories of child mortality for the next decade, we present the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2019 findings for all-cause mortality and cause-specific mortality in children younger than 5 years of age, with multiple scenarios for child mortality in 2030 that include the consideration of potential effects of COVID-19, and a novel framework for quantifying optimal child survival. Methods We completed all-cause mortality and cause-specific mortality analyses from 204 countries and territories for detailed age groups separately, with aggregated mortality probabilities per 1000 livebirths computed for neonatal mortality rate (NMR) and under-5 mortality rate (USMR). Scenarios for 2030 represent different potential trajectories, notably including potential effects of the COVID-19 pandemic and the potential impact of improvements preferentially targeting neonatal survival. Optimal child survival metrics were developed by age, sex, and cause of death across all GBD location-years. The first metric is a global optimum and is based on the lowest observed mortality, and the second is a survival potential frontier that is based on stochastic frontier analysis of observed mortality and Healthcare Access and Quality Index. Findings Global U5MR decreased from 71.2 deaths per 1000 livebirths (95% uncertainty interval WI] 68.3-74-0) in 2000 to 37.1 (33.2-41.7) in 2019 while global NMR correspondingly declined more slowly from 28.0 deaths per 1000 live births (26.8-29-5) in 2000 to 17.9 (16.3-19-8) in 2019. In 2019,136 (67%) of 204 countries had a USMR at or below the SDG 3.2 threshold and 133 (65%) had an NMR at or below the SDG 3.2 threshold, and the reference scenario suggests that by 2030,154 (75%) of all countries could meet the U5MR targets, and 139 (68%) could meet the NMR targets. Deaths of children younger than 5 years totalled 9.65 million (95% UI 9.05-10.30) in 2000 and 5.05 million (4.27-6.02) in 2019, with the neonatal fraction of these deaths increasing from 39% (3.76 million 95% UI 3.53-4.021) in 2000 to 48% (2.42 million; 2.06-2.86) in 2019. NMR and U5MR were generally higher in males than in females, although there was no statistically significant difference at the global level. Neonatal disorders remained the leading cause of death in children younger than 5 years in 2019, followed by lower respiratory infections, diarrhoeal diseases, congenital birth defects, and malaria. The global optimum analysis suggests NMR could be reduced to as low as 0.80 (95% UI 0.71-0.86) deaths per 1000 livebirths and U5MR to 1.44 (95% UI 1-27-1.58) deaths per 1000 livebirths, and in 2019, there were as many as 1.87 million (95% UI 1-35-2.58; 37% 95% UI 32-43]) of 5.05 million more deaths of children younger than 5 years than the survival potential frontier. Interpretation Global child mortality declined by almost half between 2000 and 2019, but progress remains slower in neonates and 65 (32%) of 204 countries, mostly in sub-Saharan Africa and south Asia, are not on track to meet either SDG 3.2 target by 2030. Focused improvements in perinatal and newborn care, continued and expanded delivery of essential interventions such as vaccination and infection prevention, an enhanced focus on equity, continued focus on poverty reduction and education, and investment in strengthening health systems across the development spectrum have the potential to substantially improve USMR. Given the widespread effects of COVID-19, considerable effort will be required to maintain and accelerate progress. Copyright (C) 2021 The Author(s). Published by Elsevier Ltd
Suppression in Pb-Pb Collisions at the LHC.
The production of the ψ(2S) charmonium state was measured with ALICE in Pb-Pb collisions at sqrt[s_{NN}]=5.02 TeV, in the dimuon decay channel. A significant signal was observed for the first time at LHC energies down to zero transverse momentum, at forward rapidity (2.5<y<4). The measurement of the ratio of the inclusive production cross sections of the ψ(2S) and J/ψ resonances is reported as a function of the centrality of the collisions and of transverse momentum, in the region p_{T}<12 GeV/c. The results are compared with the corresponding measurements in pp collisions, by forming the double ratio [σ^{ψ(2S)}/σ^{J/ψ}]_{Pb-Pb}/[σ^{ψ(2S)}/σ^{J/ψ}]_{pp}. It is found that in Pb-Pb collisions the ψ(2S) is suppressed by a factor of ∼2 with respect to the J/ψ. The ψ(2S) nuclear modification factor R_{AA} was also obtained as a function of both centrality and p_{T}. The results show that the ψ(2S) resonance yield is strongly suppressed in Pb-Pb collisions, by a factor of up to ∼3 with respect to pp. Comparisons of cross section ratios with previous Super Proton Synchrotron findings by the NA50 experiment and of R_{AA} with higher-p_{T} results at LHC energy are also reported. These results and the corresponding comparisons with calculations of transport and statistical models address questions on the presence and properties of charmonium states in the quark-gluon plasma formed in nuclear collisions at the LHC
Mathematical Modeling for Optimal Management of Human Resources in Banking Sector of Bangladesh
A new mathematical model on human resources divided employees into two compartments, namely, fresher and expert employees, has been designed and analyzed. A system of ordinary nonlinear differential equations has three state variables including vacancies. This model describes the dynamics of the number of fresher employees and expert employees as well as vacancies and shows the impacts of training programs and benefits of provided facilities for employees. The equilibria of this proposed model are determined, and its stability at these points is checked. Moreover, characteristics of state variables with respect to parameters have been discussed. Using two optimal control variables, this study finds the maximum number of experts including the minimum cost of provided facilities as well as the training program based on Pontryagin’s maximum principle
Mathematical Analysis of the Transmission Dynamics of Skin Cancer Caused by UV Radiation
Nowadays, skin cancer is a worldwide panic. It is related to ultraviolet radiation. In this paper, we have formulated a SIRS type mathematical model to show the effects of ultraviolet radiation on skin cancer. At first, we have showed the boundedness and positivity of the model solutions to verify the model’s existence and uniqueness. The boundedness and positivity gave the solutions of our model bounded and positive, which was very important for real-world situation because in real world, population cannot be negative. Then, we have popped out all the equilibrium points of our model and verified the stability of the equilibrium points. This stability test expressed some physical situation of our model. The disease-free equilibrium point is locally asymptotically stable if R01, then it is unstable. Again, the endemic equilibrium point is stable, if R0>1 and unstable if R0<1. In order to understand the dynamical behavior of the model’s equilibrium points, we examined the phase portrait. We also have observed the sensitivity of the model parameters. After this, we have investigated the different scenarios of bifurcations of the model’s parameters. At the set of Hopf bifurcation parameters when infection rate due to UV rays is less than α1=0.01, proper control may eradicate the existence of disease. From transcritical bifurcation, we can say when recovery rate greater than 1.9, then the disease of skin cancer can be eliminated and when recovery rate less than 1.9 then the disease of skin cancer cannot be eradicated. Finally, numerical analysis is done to justify our analytical findings
- …